The changing game for drug and device marketing, however, is governed by antiquated and inadequate rules created for traditional print and broadcast advertising by the Food and Drug Administration (FDA). How the FDA will deal with such advanced communication technology that can go viral and just as quickly disappear is the question that the industry is eager to have answered Read More : http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900970SEMINAR?channel=mailer&camp=Seminar&AdGroup=allconferencealerts_MAY_2017_SEO

Date : 18th May 2017 to 19th May 2017

Place : United States, Chicago, il

Website :http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900970SEMINAR?channel=mailer&camp=Seminar&AdGroup=allconferencealerts_MAY_2017_SEO

Contact Person:Eevnt Manager

Description:

The changing game for drug and device marketing, however, is governed by antiquated and inadequate rules created for traditional print and broadcast advertising by the Food and Drug Administration ("FDA"). How the FDA will deal with such advanced communication technology that can go "viral" and just as quickly disappear is the question that the industry is eager to have answered Read More : http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900970SEMINAR?channel=mailer&camp=Seminar&AdGroup=allconferencealerts_MAY_2017_SEO

The changing game for drug and device marketing, however, is governed by antiquated and inadequate rules created for traditional print and broadcast advertising by the Food and Drug Administration (FDA). How the FDA will deal with such advanced communication technology that can go viral and just as quickly disappear is the question that the industry is eager to have answered Read More : http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900970SEMINAR?channel=mailer&camp=Seminar&AdGroup=allconferencealerts_MAY_2017_SEO will be held in Chicago, il,United States on date 2017-05-19

---

Deadline for abstracts/proposals : 17th May 2017

Keynote Speakers : David R. Dills, Global Regulatory Affairs & Compliance Consultant currently provides regulatory affairs and compliance consultative services for early-stage and established Class I/II/III device, IVD, biopharmaceutical, cosmetics and nutraceutical manufacturers on the global landscape, and has an accomplished record with more than 27 years of experience in the areas of Regulatory Affairs, Compliance and Quality Systems. He has been previously employed, with increasing responsibilities by dev

Conference Highlights :Management responsible for regulatory and GMP/GLP/GCP compliance and seeking a better understanding of FDA, advertising and promotional requirements, regulatory actions and how they can improve their own firm's operations and monitoring of their state of compliance and meeting requirements Individuals who come in contact with regulatory inspectors Auditors Compliance/Regulatory affairs professionals QA/QC professionals Senior management executives Manufacturing managers, supervisors &

Venue :Chicago, IL, United States

Check the event website for more details.